Gene · 3239
Papers1,817
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,817
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies. | J Exp Clin Cancer Res | 2024 | 38822401 | PubTator, text mining | PubMed |
| An observational study investigating soluble immune checkpoints as indicators of severe COVID-19. | Microbiol Spectr | 2024 | 38809008 | PubTator, text mining | PubMed |
| Atomic Insight into the Enzymatic Selectivity of Acetyltransferase for Endogenous Polyamines. | Chemphyschem | 2024 | 38772911 | PubTator, text mining | PubMed |
| Pursuing Clinical Predictors and Biomarkers for Progression in ILD: Analysis of the Pulmonary Fibrosis Foundation (PFF) Registry. | Lung | 2024 | 38753183 | PubTator, text mining | PubMed |
| A Study on the Immunoregulatory Role of the PD1 Pathway in Juvenile Idiopathic Arthritis. | Mediterr J Rheumatol | 2024 | 38736964 | PubTator, text mining | PubMed |
| Peripheral Soluble Immune Checkpoint-Related Proteins Were Associated with Survival and Treatment Efficacy of Osteosarcoma Patients, a Cohort Study. | Cancers (Basel) | 2024 | 38730580 | PubTator, text mining | PubMed |
| Immune checkpoint activity exacerbate renal interstitial fibrosis progression by enhancing PD-L1 expression in renal tubular epithelial cells. | Transl Res | 2024 | 38723861 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis reveals characteristic transcription factors in polydactyly. | Eur Rev Med Pharmacol Sci | 2024 | 38708480 | PubTator, text mining | PubMed |
| Emerging insights into transcriptional condensates. | Exp Mol Med | 2024 | 38658705 | PubTator, text mining | PubMed |
| Soluble Programmed Cell Death 1 Protein Is a Promising Biomarker to Predict Severe Liver Inflammation in Chronic Hepatitis B Patients. | ACS Omega | 2024 | 38617617 | PubTator, text mining | PubMed |
| The Influence of Drug-Eluting Beads Transarterial Chemoembolization on Serum Levels of Soluble Programmed Cell Death Protein-1 in Advanced Hepatocellular Carcinoma Patients. | J Hepatocell Carcinoma | 2024 | 38559553 | PubTator, text mining | PubMed |
| A Multi-Task Network Based on Dual-Neck Structure for Autonomous Driving Perception. | Sensors (Basel) | 2024 | 38475082 | PubTator, text mining | PubMed |
| Comprehensive Co-Inhibitory Receptor (Co-IR) Expression on T Cells and Soluble Proteins in Rheumatoid Arthritis. | Cells | 2024 | 38474367 | PubTator, text mining | PubMed |
| Transforming growth factor-β1 and soluble co-inhibitory immune checkpoints as putative drivers of immune suppression in patients with basal cell carcinoma. | Transl Oncol | 2024 | 38308919 | PubTator, text mining | PubMed |
| Inhibition of HOXD11 promotes cartilage degradation and induces osteoarthritis development. | J Orthop Surg Res | 2024 | 38308324 | PubTator, text mining | PubMed |
| RExPRT: a machine learning tool to predict pathogenicity of tandem repeat loci. | Genome Biol | 2024 | 38297326 | PubTator, text mining | PubMed |
| Detection of toxigenic M1UK lineage group A Streptococcus clones in Taiwan. | J Microbiol Immunol Infect | 2024 | 38278671 | PubTator, text mining | PubMed |
| The genetic and immune features of salivary gland secretory carcinoma with high-grade transformation. | Oral Dis | 2024 | 38263601 | PubTator, text mining | PubMed |
| BTLA biology in cancer: from bench discoveries to clinical potentials. | Biomark Res | 2024 | 38233898 | PubTator, text mining | PubMed |
| Affinity-optimizing enhancer variants disrupt development. | Nature | 2024 | 38233525 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3239/papers?page=7